News

Spinout company Stroma Biosciences selected to take place in Accelerate@Babraham Start-up Programme

22 September 2020

Spinout company Stroma Biosciences, co-founded by Cambridge Stem Cell Institute and Department of Haematology PI Dr Ingo Ringshausen and post-doc Dr Eugene Park has been selected as one of four start-up companies taking part in the Accelerate@Babraham Start-up Programme.

Stem Cell Institute PIs awarded funding for UK/Japan collaborative projects in regenerative medicine

22 September 2020

Stem Cell Institute PIs and affiliates have been awarded funding from MRC-AMED joint call for collaborations between academics in the UK and Japan in the field of regenerative medicine and stem cell research.

‘The Blood of the Future Could be Made in a Lab’ – Dr Cédric Ghevaert interviewed by the Wall Street Journal

9 September 2020

In their latest The Future of Everything podcast, the Wall Street Journal explore the possibility of making blood in the lab and feature an interview with Cambridge Stem Cell Institute PI Dr Cédric Ghevaert.

Towards precision medicine: Funding awarded from the Rosetrees Trust for project focussing on patients with myeloid stem cell cancers

30 July 2020

Group Leader Dr Jyoti Nangalia has been awarded funding from the Rosetrees Trust for her project “Towards precision medicine: Integrating personalised prognostic predictions for patients with myeloid stem cell cancers into clinical care.”

Stem Cell Institute Group Leaders elected as EMBO members

6 July 2020

Two Cambridge Stem Cell Institute Group Leaders are among the 63 scientists from around the world elected this year as Members and Associate Members of the European Molecular Biology Organisation (EMBO).

Institute PIs awarded university promotions

26 June 2020

Many congratulations to our institute and affiliate PIs who have been awarded promotions through the University’s Academic Promotions process recognising their outstanding work.

Potentially cancerous cells kept in check by competitive neighbours, study of oesophagus finds

15 May 2020

The expansion of ‘mutant’ cells that could lead to cancer is often kept in check by their neighbours, research from the Wellcome Sanger Institute, the University of Cambridge and their collaborators has found. The team discovered that when equally-matched cells in the oesophagus of mice coincided, they acted as a brake on one another’s growth.

Professor Ludovic Vallier elected to the Fellowship of the Academy of Medical Sciences

13 May 2020

The Academy of Medical Sciences has elected 50 of the UK’s most prominent biomedical and health scientists to their Fellowship.

Key nose cells identified as likely COVID-19 virus entry points

23 April 2020

Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to get into our cells.

Uncovering the regulatory blueprint for early mammalian organ formation

30 March 2020

Research published in Nature Cell Biology today (Monday 30th March) has revealed insights into the molecular regulation of mammalian organ development.